According to Sutro Biopharma's latest financial reports and stock price the company's current Operating Margin is -45.38%. At the end of 2022 the company had an Operating Margin of -172.20%.
Year | Operating Margin | Change |
---|---|---|
2022 | -172.20% | 0.97% |
2021 | -170.55% | 127.52% |
2020 | -74.96% | -42.53% |
2019 | -130.44% | 41.89% |
2018 | -91.93% | 141.59% |
2017 | -38.05% | -1435.39% |
2016 | 2.85% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
-8,391.15% | 18,390.86% | ๐บ๐ธ USA | |
-16.56% | -63.51% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.